Extra virgin vs regular olive oil: the same fat with different phenols

Across 13 randomized trials in 611 mostly healthy adults, virgin and extra virgin olive oil, with high or low phenol content, lowered systolic blood pressure by about 2.9 to 3.0 mmHg compared with refined olive oil, evidence the authors rated low to moderate in certainty. The same network meta-analysis found no difference between the oils in total cholesterol, HDL cholesterol, triglycerides or diastolic pressure. High-phenol oil lowered LDL cholesterol by 5.4 mg/dL (0.14 mmol/L) more than low-phenol oil (95% CI 0.01 to 0.28). The fat itself barely differs. In USDA analyses, extra virgin (36 samples) and extra light olive oil (8 samples) each carry about 15 g saturated fat per 3.5 oz (100 g), with 69 g and 67 g monounsaturated fat, and that dataset does not measure phenols. In a crossover trial of 200 healthy European men taking 1.7 tbsp (25 mL) a day for 3-week periods, oils with 2.7, 164 and 366 mg/kg of phenols raised HDL cholesterol by 0.025, 1.2 and 1.7 mg/dL (0.032 and 0.045 mmol/L), with short periods and self-reported diet.

How much is actually in it

• Per 100 g, extra virgin and extra light olive oil have almost the same fat profile in USDA Foundation data, about 15 g saturated, 67 to 69 g monounsaturated and 9 to 10 g polyunsaturated fat. — USDA Foundation Foods, 36 samples of extra virgin and 8 samples of extra light olive oil (n = 36 + 8 samples) Evidence E source
  Saturated 15.4 g (13.1-18.8) vs 15.82 g (14.3-18.13); MUFA 69.2 g (59.2-74.2) vs 66.63 g (60.38-71.08); PUFA 9.07 g (5.81-15.5) vs 10.37 g (7.25-14.94)
• The UK composition table lists olive oil at 899 calories and 99.9 g fat per 3.5 oz (100 g), with 73.0 g monounsaturated and 14.3 g saturated fat, without separating extra virgin from refined. — CoFID 2021, food code 17-038, oil, olive Evidence E source
  899 calories, fat 99.9 g, MUFA 73.0 g, saturated 14.3 g, PUFA 8.2 g per 3.5 oz (100 g)
• In a crossover RCT of 200 healthy men taking 1.7 tbsp (25 mL) a day for 3 weeks, HDL cholesterol rose in step with the olive oil's phenolic content, by 0.025, 1.2 and 1.7 mg/dL (0.032 and 0.045 mmol/L) for oils with 2.7, 164 and 366 mg/kg. — healthy men, 6 centers in 5 European countries, 25 mL/day, 3-week periods (n = 200) Evidence B source
  HDL +0.025 (low), +0.032 (medium), +1.7 mg/dL (0.045 mmol/L) (high phenolic)

What a real portion looks like

• The US dietary survey codes one tablespoon of olive oil as 14 g, which is also its default amount when quantity is not reported. — USDA FNDDS portion weights, olive oil (code 82104000) Evidence E source
  1 tablespoon = 14 g, 1 cup = 224 g

What your body absorbs

• In a double-blind study of 20 volunteers given 5 mg hydroxytyrosol in different foods, extra virgin olive oil gave the highest urinary recovery, 0.86 versus 0.63 ug/mg creatinine from fortified refined olive oil. — 20 volunteers, single 5 mg hydroxytyrosol dose in diverse food matrices (n = 20) Evidence B source
  Urinary hydroxytyrosol 0.86 (EVOO) vs 0.63 (fortified refined olive oil) vs 0.55 (flax) vs 0.33 (grapeseed) ug/mg creatinine

What cooking and storage change

• In a crossover RCT in 20 obese adults, breakfasts cooked in virgin olive oil after 20 frying cycles caused less postprandial oxidative stress than sunflower oil heated the same way. — obese adults, four breakfasts with oils subjected to 20 heating cycles (n = 20) Evidence B source
  Sunflower oil lowered plasma GSH and raised protein carbonyls vs virgin olive oil; direction only
• In a small randomized meal study, 12 obese insulin-resistant women had lower insulin and C-peptide after a meal with food fried in extra virgin olive oil than after the same meal with raw oil, with no difference in 5 lean women. — 12 obese insulin-resistant women and 5 lean women, single test meals with 25 g oil (n = 17) Evidence B source
  C-peptide AUC higher with raw oil meal at 120-180 min (P = .002-.004) in obese women

What it does to your health

• A network meta-analysis of 13 RCTs in 611 people found high-phenolic virgin olive oil lowered systolic blood pressure by about 3 mmHg versus refined olive oil, with no difference in total cholesterol, HDL or triglycerides. — 13 RCTs of at least 3 weeks, mainly healthy adults aged 26-70 (n = 611) Evidence A source
  SBP MD -2.99 to -2.87 mmHg vs refined; LDL MD -5.4 mg/dL (-11 to -0.39; metric: -0.14 mmol/L, -0.28 to -0.01) high vs low phenolic; certainty low to moderate
• Observational data within the PREDIMED trial link the highest third of extra virgin olive oil intake, about 49 g a day, with 25% fewer cardiovascular events, while common olive oil showed no clear association. — 7102 high-risk adults aged 55-80 in Spain, median 4.7 years (n = 7102) Evidence C source
  EVOO top tertile HR 0.75 (0.60-0.94); common olive oil HR per 10 g/d 0.93 (0.87-1.00)
• In a crossover RCT of 50 Australian adults drinking 2 fl oz (60 mL) a day for 3 weeks, high-polyphenol and low-polyphenol olive oil did not differ in blood pressure change, though systolic pressure fell 2.5 mmHg on the high-polyphenol oil. — healthy adults, mean age 38.5, 60 mL/day, 3-week periods (n = 50) Evidence B source
  No between-treatment difference; within HPOO peripheral SBP -2.5 mmHg (-4.7 to -0.3)
• Observational data link higher olive oil intake with 13% lower diabetes risk in cohorts, and the extra virgin subgroup showed a 25% lower risk. — 10 studies (4 cohorts, 6 RCTs), more than 500,000 subjects (n = 10 studies) Evidence C source
  Cohorts RR 0.87 (0.83-0.92); EVOO subgroup RR 0.75 (0.65-0.87)
• Observational data link each extra 25 g a day of olive oil with 26% lower stroke risk in cohorts, but not with lower coronary heart disease risk. — case-control, cohort and one intervention study, 101,460 participants for CHD and 38,673 for stroke (n = 140133) Evidence C source
  Stroke RR 0.74 (0.60-0.92); CHD RR 0.96 (0.78-1.18) per 25 g

What people believe that the data does not support

• The EU authorizes the label claim that olive oil polyphenols contribute to the protection of blood lipids from oxidative stress. — EU Register on nutrition and health claims, claim POL-HC-6431 Evidence E source
  Status Authorised
• The EU did not authorize the general claim that olive oil promotes heart health. — EU Register on nutrition and health claims, claim POL-HC-7679 Evidence E source
  Status Non-authorized

Who this works differently for

• In a double-blind crossover RCT of 80 Japanese men, 14 g a day of extra virgin versus refined olive oil for 3 weeks did not lower oxidized LDL overall, with a benefit only in men aged 35-50. — healthy Japanese men aged 35-64, 14 g/day for 3 weeks (n = 80) Evidence B source
  No overall difference in MDA-LDL; larger reduction in 35-50 subgroup (p < 0.025)

What is still unknown

• A meta-analysis of 51 RCTs in 4334 adults found olive oil did not significantly change blood glucose, with a HOMA-IR improvement only at 25-50 g a day. — 51 RCTs of olive oil interventions in adults (n = 4334) Evidence A source
  Glucose WMD -0.04 mg/dL (-0.1 to 0.02), P = 0.18; HOMA-IR improved at 25-50 g/day
• An umbrella review of 17 systematic reviews rated the olive oil evidence as highly heterogeneous and low quality and called for trials that isolate specific olive oil components. — 17 systematic reviews of randomized trials and observational studies (n = 17 reviews) Evidence C source
  Evidence gap statement

The bottom line

Smaller trials pull in different directions. In 50 Australian adults drinking 2 fl oz (60 mL) a day for 3 weeks, high- and low-polyphenol oils did not differ in blood pressure change, and systolic pressure fell 2.5 mmHg (95% CI 0.3 to 4.7) only within the high-polyphenol period. In 80 healthy Japanese men taking 14 g a day for 3 weeks, extra virgin oil did not lower oxidized LDL more than refined oil overall. A benefit showed up only in the subgroup aged 35 to 50. In 20 volunteers given 5 mg of hydroxytyrosol in different foods, extra virgin olive oil left the most in urine, 0.86 ug/mg creatinine against 0.63 from refined olive oil fortified with it, after a single dose. For blood sugar, a meta-analysis of 51 randomized trials in 4334 adults found olive oil did not significantly change fasting glucose (-0.04 mg/dL, 95% CI -0.1 to 0.02), with all types of olive oil pooled. Insulin resistance measured as HOMA-IR improved only at 25 to 50 g a day. Cohort data point in a similar direction and cannot show cause. Within the PREDIMED trial, 7102 Spanish adults aged 55 to 80 at high cardiovascular risk were followed for a median 4.7 years. Those in the top third of extra virgin intake, about 49 g a day, had 25% fewer cardiovascular events (HR 0.75, 95% CI 0.60 to 0.94), and that intake was chosen, not randomized. Common olive oil showed no significant association (HR 0.93 per 10 g a day, 95% CI 0.87 to 1.00). Across cohorts, more olive oil is linked with 13% lower diabetes risk (RR 0.87, 95% CI 0.83 to 0.92) and 25% lower in the extra virgin subgroup (RR 0.75, 95% CI 0.65 to 0.87). Each extra 25 g a day is linked with 26% lower stroke risk in cohorts (RR 0.74, 95% CI 0.60 to 0.92), with no link to coronary heart disease (RR 0.96, 95% CI 0.78 to 1.18), and that analysis does not separate types of oil. Two small meal studies looked at heated oil. Twenty obese adults ate breakfasts cooked in oils that had been through 20 heating cycles, and virgin olive oil caused less oxidative stress after the meal than sunflower oil treated the same way, with no effect size given in the abstract. In 12 obese insulin-resistant women, food fried in extra virgin olive oil gave lower insulin and C-peptide after a single meal than the same meal with raw oil. Five lean women showed no difference. On labels, the EU allows olive oil polyphenols to claim they help protect blood lipids from oxidative stress, and the minimum polyphenol content that goes with that claim is not in our data. It refused the broad claim that olive oil promotes heart health. Any olive oil is almost pure fat, 899 calories per 3.5 oz (100 g) in the UK table, which lists a single olive oil row, and the US survey counts a tablespoon as 14 g. We have no card on allergy, pregnancy, medicines or any other safety question for olive oil, so this page has no caution section. An umbrella review of 17 systematic reviews rated the olive oil evidence as highly heterogeneous and low in quality, and asked for trials that isolate specific components of the oil.

Sources

1. evoo-daily-r1-01 · reference dataset
   Oil, olive, extra virgin (FDC 748608): Fatty acids, total saturated 15.4 g, range 13.1-18.8, n=36 · total monounsaturated 69.2 g, range 59.2-74.2, n=36 · total polyunsaturated 9.07 g, range 5.81-15.5, n=36 | Oil, olive, extra light: total saturated 15.82 g, range 14.3-18.13, n=8 · total monounsaturated 66.63 g, range 60.38-71.08, n=8 · total polyunsaturated 10.37 g, range 7.25-14.94, n=8
   USDA FoodData Central Foundation Foods, release 2026-04-30 · checked 2026-09-29
2. evoo-daily-r1-02 · reference dataset
   CoFID 17-038 Oil, olive: Energy 899 kcal · Fat 99.9 g · Mono FA 73.00 g · Satd FA 14.30 g · Poly FA 8.20 g
   CoFID 2021, Public Health England (OGL v3.0), code 17-038 · checked 2026-09-29
3. evoo-daily-r1-05 · RCT, crossover
   PARTICIPANTS: 200 healthy male volunteers. ... Olive oils had low (2.7 mg/kg of olive oil), medium (164 mg/kg), or high (366 mg/kg) phenolic content but were otherwise similar. ... A linear increase in high-density lipoprotein (HDL) cholesterol levels was observed for low-, medium-, and high-polyphenol olive oil: mean change, 0.025 mmol/L (95% CI, 0.003 to 0.05 mmol/L), 0.032 mmol/L (CI, 0.005 to 0.05 mmol/L), and 0.045 mmol/L (CI, 0.02 to 0.06 mmol/L), respectively.
   Ann Intern Med, 2006 · checked 2026-09-29
4. evoo-daily-r1-03 · reference dataset
   FNDDS 82104000 Olive oil (fdc 2710186): 1 tablespoon 14 g · 1 cup 224 g · Quantity not specified 14 g
   USDA FNDDS 2021-2023 (FoodData Central) · checked 2026-09-29
5. evoo-daily-r1-09 · RCT, crossover
   A double-blind study was performed including 20 volunteers who ingested 5 mg of hydroxytyrosol through diverse food matrices ... Regarding the hydroxytyrosol bioavailability, the intake of extra virgin olive oil, as well as fortified refined olive, flax, and grapeseed oils provided significantly higher urinary contents (0.86, 0.63, 0.55, and 0.33 µg/mg creatinine, respectively) compared with basal urine
   Eur J Nutr, 2021 · checked 2026-09-29
6. evoo-daily-r1-10 · RCT, crossover
   Twenty obese people received four breakfasts following a randomised crossover design consisting of different oils (virgin olive oil (VOO), sunflower oil (SFO), and a mixed seed oil (SFO/canola oil) with added dimethylpolysiloxane (SOX) or natural antioxidants from olives (SOP)), which were subjected to 20 heating cycles. ... Oils with phenolic compounds, whether natural (VOO) or artificially added (SOP), or with artificial antioxidant (SOX), could reduce postprandial oxidative stress compared with sunflower oil.
   Food Chem, 2013 · checked 2026-09-29
7. evoo-daily-r1-11 · RCT, crossover
   After an overnight fast, 12 obese insulin-resistant women (body mass index [BMI], 32.8 ± 2.2 kg/m(2)) and five lean subjects (BMI, 22.2 ± 1.2 kg/m(2)) were randomly assigned to receive two different meals (designated A and B). ... No differences were found in lean subjects. This study demonstrated that in obese, insulin-resistant women, food fried in extra-virgin olive oil significantly reduced both insulin and C-peptide responses after a meal.
   J Med Food, 2011 · checked 2026-09-29
8. evoo-daily-r1-04 · network meta-analysis of RCTs
   Thirteen RCTs (16 reports) with 611 mainly healthy participants (mean age: 26-70 years) were identified. No differences for total cholesterol, HDL-cholesterol, triacylglycerols, and diastolic blood pressure were observed comparing ROO, MOO, LP(E)VOO and HP(E)VOO. HP(E)VOO slightly reduce LDL-cholesterol (LDL-C) compared to LP(E)VOO (mean difference [MD]: -0.14 mmol/L, 95%-CI: -0.28, -0.01). Both, HP(E)VOO and LP(E)VOO reduces SBP compared to ROO (range of MD: -2.99 to -2.87 mmHg)
   Nutr Metab Cardiovasc Dis, 2019 · checked 2026-09-29
9. evoo-daily-r1-06 · cohort analysis within RCT
   Participants in the highest tertile of cumulative EVOO intake (mean: 49.2 g/d) had a 25% lower risk of the composite outcome (HR: 0.75; 95% CI: 0.60-0.94), with significant reductions in several individual CVD outcomes. ... COO consumption was not significantly associated with CVD risk when mutually adjusted for EVOO (HRper 10 g/d: 0.93; 95% CI: 0.87-1.00).
   Am Heart J, 2026 · checked 2026-09-29
10. evoo-daily-r1-08 · RCT, crossover
    In a double-blind, randomized, controlled cross-over trial, 50 participants (age 38.5 ± 13.9 years, 66% female) were randomized to consume 60 mL/day of either HPOO (360 mg/kg polyphenols) or LPOO (86 mg/kg polyphenols) for three weeks. ... No significant differences were observed in the changes from baseline to follow up between the two treatments. However, a significant decrease in peripheral and central systolic BP (SBP) by 2.5 mmHg (95% CI: -4.7 to -0.3) and 2.7 mmHg (95% CI: -4.7 to -0.6), respectively, was observed after HPOO consumption.
    Nutrients, 2020 · checked 2026-09-29
11. evoo-daily-r1-13 · meta-analysis, mixed designs
    A 13% (RR = 0.87, 95%CI = 0.83 - 0.92, P < 0.01) decreased risk of diabetes was shown in Cohort study ... and extra virgin olive oil ( RR = 0.75, 95%CI = 0.65-0.87, P < 0.01).
    J Health Popul Nutr, 2025 · checked 2026-09-29
12. evoo-daily-r1-14 · meta-analysis, mainly observational
    The random-effects model assessing CHD as an outcome showed a relative risk (RR) of 0.73 (95% CI 0.44, 1.21) in case-control studies and 0.96 (95% CI 0.78, 1.18) in cohort studies for a 25 g increase in olive oil consumption. In cohort studies, the random-effects model assessing stroke showed a RR of 0.74 (95% CI 0.60, 0.92).
    Br J Nutr, 2014 · checked 2026-09-29
13. evoo-daily-r1-16 · regulatory register
    POL-HC-6431 Olive oil polyphenols Olive oil polyphenols contribute to the protection of blood lipids from oxidative stress Authorised
    EU Register on nutrition and health claims, claim POL-HC-6431, snapshot 2026-09-21 · checked 2026-09-29
14. evoo-daily-r1-17 · regulatory register
    POL-HC-7679 Olive Oil Olive Oil promotes your heart health Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7679, snapshot 2026-09-21 · checked 2026-09-29
15. evoo-daily-r1-07 · RCT, crossover
    This randomized controlled double-blind crossover trial with a 2-week washout enrolled 80 healthy Japanese men aged 35-64 years. Participants ingested either 14 g of extra virgin olive oil containing 5.0 mg of olive oil polyphenols (test food) or 14 g of refined olive oil containing 0.3 mg of olive oil polyphenols (control food) for 3 weeks. ... In all of the participants (35-64 years), there were no significant differences in MDA-LDL between the control and test groups. However, in the 35-50 years subgroup, ingestion of olive oil polyphenols led to a significantly larger reduction in MDA-LDL as compared with the control group (p < 0.025).
    Nutrients, 2024 · checked 2026-09-29
16. evoo-daily-r1-12 · meta-analysis of RCTs
    51 trials (n = 4334 participants) were included in the meta-analysis. We found the consumption of olive oil was not associated with statistically significant changes in blood glucose (WMD = -0.04 mg dL-1; 95% CI, -0.1 to 0.02; P = .18; I2 = 27.05%) ... However, a daily dose of 25-50 g significantly improves the HOMA-IR parameter, suggesting a potential benefit for diabetes management.
    Nutr Rev, 2026 · checked 2026-09-29
17. evoo-daily-r1-15 · umbrella review
    Given the high heterogeneity and low quality of evidence, further studies involving randomized trials are imperative. Prioritizing an in-depth analysis of specific olive oil components and using a control group with distinct characteristics and different effects is strongly recommended.
    Nutr Rev, 2025 · checked 2026-09-29